Cecha
Obesity
Accumulation of substantial excess body fat.
Podsumowanie
- Znana także jako
- Having too much body fat
- Układ organizmu
- Growth abnormality
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Obesity, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test320 genów powiązanych z Obesity
Zmiany w tych genach powodują rzadkie choroby, w których występuje Obesity. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ADCY3adenylate cyclase 3 | Zawsze | W 1 chorobie |
| AFF4ALF transcription elongation factor 4 | Zawsze | W 2 chorobach |
| ALMS1ALMS1 centrosome and basal body associated protein | Zawsze | W 2 chorobach |
| ARL13BARF like GTPase 13B | Zawsze | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Zawsze | W 2 chorobach |
| BBS10Bardet-Biedl syndrome 10 | Zawsze | W 2 chorobach |
| BBS2Bardet-Biedl syndrome 2 | Zawsze | W 3 chorobach |
| BBS5Bardet-Biedl syndrome 5 | Zawsze | W 2 chorobach |
| BBS7Bardet-Biedl syndrome 7 | Zawsze | W 2 chorobach |
| CACHD1cache domain containing 1 | Zawsze | W 1 chorobie |
| CANT1calcium activated nucleotidase 1 | Zawsze | W 1 chorobie |
| CEP290centrosomal protein 290 | Zawsze | W 2 chorobach |
| CNTNAP2contactin associated protein 2 | Zawsze | W 2 chorobach |
| COA3cytochrome c oxidase assembly factor 3 | Zawsze | W 1 chorobie |
| IFT140intraflagellar transport 140 | Zawsze | W 1 chorobie |
| IFT172intraflagellar transport 172 | Zawsze | W 3 chorobach |
| IFT27intraflagellar transport 27 | Zawsze | W 2 chorobach |
| IFT74intraflagellar transport 74 | Zawsze | W 2 chorobach |
| KDM6Alysine demethylase 6A | Zawsze | W 2 chorobach |
| KMT2Dlysine methyltransferase 2D | Zawsze | W 2 chorobach |
| LEPleptin | Zawsze | W 2 chorobach |
| LEPRleptin receptor | Zawsze | W 2 chorobach |
| LRRC7leucine rich repeat containing 7 | Zawsze | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Zawsze | W 2 chorobach |
| MC4Rmelanocortin 4 receptor | Zawsze | W 2 chorobach |
| MIA3MIA SH3 domain ER export factor 3 | Zawsze | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Zawsze | W 2 chorobach |
| MKS1MKS transition zone complex subunit 1 | Zawsze | W 2 chorobach |
| MSL2MSL complex subunit 2 | Zawsze | W 1 chorobie |
| NHLH2nescient helix-loop-helix 2 | Zawsze | W 1 chorobie |
| NOTCH3notch receptor 3 | Zawsze | W 1 chorobie |
| NTRK2neurotrophic receptor tyrosine kinase 2 | Zawsze | W 1 chorobie |
| PCSK1proprotein convertase subtilisin/kexin type 1 | Zawsze | W 2 chorobach |
| PDSS1decaprenyl diphosphate synthase subunit 1 | Zawsze | W 1 chorobie |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Zawsze | W 1 chorobie |
| POMCproopiomelanocortin | Zawsze | W 3 chorobach |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Zawsze | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Zawsze | W 1 chorobie |
| RAP1BRAP1B, member of RAS oncogene family | Zawsze | W 1 chorobie |
| RBMXRNA binding motif protein X-linked | Zawsze | W 2 chorobach |
Pokaż jeszcze 280 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| RFC4replication factor C subunit 4 | Zawsze | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Zawsze | W 2 chorobach |
| SH3KBP1SH3 domain containing kinase binding protein 1 | Zawsze | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Zawsze | W 2 chorobach |
| SLC25A4solute carrier family 25 member 4 | Zawsze | W 1 chorobie |
| TMEM67transmembrane protein 67 | Zawsze | W 1 chorobie |
| TMLHEtrimethyllysine hydroxylase, epsilon | Zawsze | W 1 chorobie |
| TRA2Btransformer 2 beta homolog | Zawsze | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Zawsze | W 2 chorobach |
| TUBTUB bipartite transcription factor | Zawsze | W 1 chorobie |
| ARL6ARF like GTPase 6 | Bardzo często (80–99%) | W 3 chorobach |
| BBS1Bardet-Biedl syndrome 1 | Bardzo często (80–99%) | W 2 chorobach |
| BBS12Bardet-Biedl syndrome 12 | Bardzo często (80–99%) | W 2 chorobach |
| BBS4Bardet-Biedl syndrome 4 | Bardzo często (80–99%) | W 2 chorobach |
| BBS9Bardet-Biedl syndrome 9 | Bardzo często (80–99%) | W 2 chorobach |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Bardzo często (80–99%) | W 1 chorobie |
| CCDC28Bcoiled-coil domain containing 28B | Bardzo często (80–99%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Bardzo często (80–99%) | W 2 chorobach |
| CFAP418cilia and flagella associated protein 418 | Bardzo często (80–99%) | W 2 chorobach |
| CYP19A1cytochrome P450 family 19 subfamily A member 1 | Bardzo często (80–99%) | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Bardzo często (80–99%) | W 1 chorobie |
| EIF2S3eukaryotic translation initiation factor 2 subunit gamma | Bardzo często (80–99%) | W 2 chorobach |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Bardzo często (80–99%) | W 1 chorobie |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Bardzo często (80–99%) | W 1 chorobie |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Bardzo często (80–99%) | W 1 chorobie |
| LAS1LLAS1 like ribosome biogenesis factor | Bardzo często (80–99%) | W 1 chorobie |
| MAGEL2MAGE family member L2 | Bardzo często (80–99%) | W 6 chorobach |
| MEGF8multiple EGF like domains 8 | Bardzo często (80–99%) | W 2 chorobach |
| MOGmyelin oligodendrocyte glycoprotein | Bardzo często (80–99%) | W 2 chorobach |
| NDNnecdin, MAGE family member | Bardzo często (80–99%) | W 4 chorobach |
| NPHP1nephrocystin 1 | Bardzo często (80–99%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Bardzo często (80–99%) | W 4 chorobach |
| P4HTMprolyl 4-hydroxylase, transmembrane | Bardzo często (80–99%) | W 1 chorobie |
| PNPLA6patatin like domain 6, lysophospholipase | Bardzo często (80–99%) | W 2 chorobach |
| RAB23RAB23, member RAS oncogene family | Bardzo często (80–99%) | W 2 chorobach |
| RAI1retinoic acid induced 1 | Bardzo często (80–99%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Bardzo często (80–99%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Bardzo często (80–99%) | W 1 chorobie |
| SH2B1SH2B adaptor protein 1 | Bardzo często (80–99%) | W 3 chorobach |
| SIM1SIM bHLH transcription factor 1 | Bardzo często (80–99%) | W 3 chorobach |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Bardzo często (80–99%) | W 6 chorobach |
| TRAPPC9trafficking protein particle complex subunit 9 | Bardzo często (80–99%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Bardzo często (80–99%) | W 2 chorobach |
| WDPCPWD repeat containing planar cell polarity effector | Bardzo często (80–99%) | W 1 chorobie |
| AKT2AKT serine/threonine kinase 2 | Często (30–79%) | W 1 chorobie |
| APOEapolipoprotein E | Często (30–79%) | W 1 chorobie |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Często (30–79%) | W 2 chorobach |
| ATP10AATPase phospholipid transporting 10A (putative) | Często (30–79%) | W 1 chorobie |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Często (30–79%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Często (30–79%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Często (30–79%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Często (30–79%) | W 1 chorobie |
| COPB1coat protein complex I subunit beta 1 | Często (30–79%) | W 1 chorobie |
| CPEcarboxypeptidase E | Często (30–79%) | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Często (30–79%) | W 2 chorobach |
| CTNNB1catenin beta 1 | Często (30–79%) | W 1 chorobie |
| CUL4Bcullin 4B | Często (30–79%) | W 1 chorobie |
| CYP7A1cytochrome P450 family 7 subfamily A member 1 | Często (30–79%) | W 1 chorobie |
| DDX6DEAD-box helicase 6 | Często (30–79%) | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Często (30–79%) | W 3 chorobach |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Często (30–79%) | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Często (30–79%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Często (30–79%) | W 2 chorobach |
| EIF4Heukaryotic translation initiation factor 4H | Często (30–79%) | W 1 chorobie |
| ELNelastin | Często (30–79%) | W 2 chorobach |
| EP300EP300 lysine acetyltransferase | Często (30–79%) | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Często (30–79%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Często (30–79%) | W 1 chorobie |
| FXR1FMR1 autosomal homolog 1 | Często (30–79%) | W 1 chorobie |
| GNASGNAS complex locus | Często (30–79%) | W 7 chorobach |
| GTF2Igeneral transcription factor IIi | Często (30–79%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Często (30–79%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Często (30–79%) | W 1 chorobie |
| HDAC4histone deacetylase 4 | Często (30–79%) | W 2 chorobach |
| HEATR3HEAT repeat containing 3 | Często (30–79%) | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Często (30–79%) | W 1 chorobie |
| HSD11B1hydroxysteroid 11-beta dehydrogenase 1 | Często (30–79%) | W 1 chorobie |
| IER3IP1immediate early response 3 interacting protein 1 | Często (30–79%) | W 1 chorobie |
| IFT54intraflagellar transport 54 | Często (30–79%) | W 1 chorobie |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Często (30–79%) | W 1 chorobie |
| KIDINS220kinase D interacting substrate 220 | Często (30–79%) | W 2 chorobach |
| LIMK1LIM domain kinase 1 | Często (30–79%) | W 1 chorobie |
| MEG3maternally expressed 3 | Często (30–79%) | W 3 chorobach |
| METTL27methyltransferase like 27 | Często (30–79%) | W 1 chorobie |
| MKRN3makorin ring finger protein 3 | Często (30–79%) | W 1 chorobie |
| MLXIPLMLX interacting protein like | Często (30–79%) | W 1 chorobie |
| MYT1Lmyelin transcription factor 1 like | Często (30–79%) | W 2 chorobach |
| NCF1neutrophil cytosolic factor 1 | Często (30–79%) | W 1 chorobie |
| NINninein | Często (30–79%) | W 1 chorobie |
| NPAP1nuclear pore associated protein 1 | Często (30–79%) | W 1 chorobie |
| OFD1OFD1 centriole and centriolar satellite protein | Często (30–79%) | W 2 chorobach |
| PGM2L1phosphoglucomutase 2 like 1 | Często (30–79%) | W 1 chorobie |
| PHF21APHD finger protein 21A | Często (30–79%) | W 1 chorobie |
| PKDCCprotein kinase domain containing, cytoplasmic | Często (30–79%) | W 1 chorobie |
| PNKPpolynucleotide kinase 3'-phosphatase | Często (30–79%) | W 2 chorobach |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 2 chorobach |
| POU3F4POU class 3 homeobox 4 | Często (30–79%) | W 1 chorobie |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 2 chorobach |
| PWAR1Prader Willi/Angelman region RNA 1 | Często (30–79%) | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Często (30–79%) | W 1 chorobie |
| RFC2replication factor C subunit 2 | Często (30–79%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Często (30–79%) | W 3 chorobach |
| SHOXSHOX homeobox | Często (30–79%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Często (30–79%) | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Często (30–79%) | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Często (30–79%) | W 1 chorobie |
| SRRM2serine/arginine repetitive matrix 2 | Często (30–79%) | W 1 chorobie |
| STX1Asyntaxin 1A | Często (30–79%) | W 1 chorobie |
| SUPT16HSPT16 homolog, facilitates chromatin remodeling subunit | Często (30–79%) | W 1 chorobie |
| TBL2transducin beta like 2 | Często (30–79%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Często (30–79%) | W 2 chorobach |
| TBX3T-box transcription factor 3 | Często (30–79%) | W 2 chorobach |
| TFE3transcription factor binding to IGHM enhancer 3 | Często (30–79%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Często (30–79%) | W 1 chorobie |
| TRIP12thyroid hormone receptor interactor 12 | Często (30–79%) | W 1 chorobie |
| UBE3Aubiquitin protein ligase E3A | Często (30–79%) | W 4 chorobach |
| UBE3Cubiquitin protein ligase E3C | Często (30–79%) | W 1 chorobie |
| VPS13Bvacuolar protein sorting 13 homolog B | Często (30–79%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Często (30–79%) | W 1 chorobie |
| WNT4Wnt family member 4 | Często (30–79%) | W 1 chorobie |
| ZNF711ZFX family zinc finger ZNF711 | Często (30–79%) | W 1 chorobie |
| ABCB4ATP binding cassette subfamily B member 4 | Czasami (5–29%) | W 1 chorobie |
| ACBD6acyl-CoA binding domain containing 6 | Czasami (5–29%) | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Czasami (5–29%) | W 1 chorobie |
| AKT1AKT serine/threonine kinase 1 | Czasami (5–29%) | W 1 chorobie |
| ALBalbumin | Czasami (5–29%) | W 1 chorobie |
| ANOS1anosmin 1 | Czasami (5–29%) | W 1 chorobie |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ATP6AP2ATPase H+ transporting accessory protein 2 | Czasami (5–29%) | W 1 chorobie |
| ATRXATRX chromatin remodeler | Czasami (5–29%) | W 1 chorobie |
| BAP1BRCA1 associated deubiquitinase 1 | Czasami (5–29%) | W 1 chorobie |
| BDNFbrain derived neurotrophic factor | Czasami (5–29%) | W 1 chorobie |
| CASZ1castor zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| CCDC141coiled-coil domain containing 141 | Czasami (5–29%) | W 1 chorobie |
| CEP164centrosomal protein 164 | Czasami (5–29%) | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Czasami (5–29%) | W 1 chorobie |
| COL10A1collagen type X alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CTSHcathepsin H | Czasami (5–29%) | W 1 chorobie |
| DCCDCC netrin 1 receptor | Czasami (5–29%) | W 1 chorobie |
| DDB1damage specific DNA binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| DUSP6dual specificity phosphatase 6 | Czasami (5–29%) | W 1 chorobie |
| DYNC2I2dynein 2 intermediate chain 2 | Czasami (5–29%) | W 1 chorobie |
| EMDemerin | Czasami (5–29%) | W 1 chorobie |
| EMX2empty spiracles homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| ERMARDER membrane associated RNA degradation | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FEZF1FEZ family zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| FGF17fibroblast growth factor 17 | Czasami (5–29%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Czasami (5–29%) | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Czasami (5–29%) | W 2 chorobach |
| FGFR3fibroblast growth factor receptor 3 | Czasami (5–29%) | W 1 chorobie |
| FHL1four and a half LIM domains 1 | Czasami (5–29%) | W 1 chorobie |
| FLRT3fibronectin leucine rich transmembrane protein 3 | Czasami (5–29%) | W 1 chorobie |
| FOXP1forkhead box P1 | Czasami (5–29%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Czasami (5–29%) | W 1 chorobie |
| GATA4GATA binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| GNAI1G protein subunit alpha i1 | Czasami (5–29%) | W 1 chorobie |
| GNAS-AS1GNAS antisense RNA 1 | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Czasami (5–29%) | W 2 chorobach |
| HCRThypocretin neuropeptide precursor | Czasami (5–29%) | W 1 chorobie |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Czasami (5–29%) | W 1 chorobie |
| HESX1HESX homeobox 1 | Czasami (5–29%) | W 2 chorobach |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Czasami (5–29%) | W 1 chorobie |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Czasami (5–29%) | W 1 chorobie |
| IL17RDinterleukin 17 receptor D | Czasami (5–29%) | W 1 chorobie |
| IL36RNinterleukin 36 receptor antagonist | Czasami (5–29%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Czasami (5–29%) | W 1 chorobie |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| LMNAlamin A/C | Czasami (5–29%) | W 3 chorobach |
| LUZP1leucine zipper protein 1 | Czasami (5–29%) | W 1 chorobie |
| MAN1B1mannosidase alpha class 1B member 1 | Czasami (5–29%) | W 1 chorobie |
| MCM3APminichromosome maintenance complex component 3 associated protein | Czasami (5–29%) | W 1 chorobie |
| MECP2methyl-CpG binding protein 2 | Czasami (5–29%) | W 2 chorobach |
| MEF2Amyocyte enhancer factor 2A | Czasami (5–29%) | W 1 chorobie |
| MMP23Bmatrix metallopeptidase 23B | Czasami (5–29%) | W 1 chorobie |
| MTFMTmitochondrial methionyl-tRNA formyltransferase | Czasami (5–29%) | W 1 chorobie |
| NDNFneuron derived neurotrophic factor | Czasami (5–29%) | W 1 chorobie |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Czasami (5–29%) | W 1 chorobie |
| OTX2orthodenticle homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| P2RY11purinergic receptor P2Y11 | Czasami (5–29%) | W 1 chorobie |
| PAX6paired box 6 | Czasami (5–29%) | W 2 chorobach |
| PDE4Dphosphodiesterase 4D | Czasami (5–29%) | W 2 chorobach |
| PDGFBplatelet derived growth factor subunit B | Czasami (5–29%) | W 1 chorobie |
| PDPNpodoplanin | Czasami (5–29%) | W 1 chorobie |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Czasami (5–29%) | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Czasami (5–29%) | W 1 chorobie |
| PRKAR1Bprotein kinase cAMP-dependent type I regulatory subunit beta | Czasami (5–29%) | W 1 chorobie |
| PRKCZprotein kinase C zeta | Czasami (5–29%) | W 1 chorobie |
| PROK2prokineticin 2 | Czasami (5–29%) | W 2 chorobach |
| PROKR2prokineticin receptor 2 | Czasami (5–29%) | W 2 chorobach |
| PRORPprotein only RNase P catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| REREarginine-glutamic acid dipeptide repeats | Czasami (5–29%) | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SATB1SATB homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| SCAF4SR-related CTD associated factor 4 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SECISBP2SECIS binding protein 2 | Czasami (5–29%) | W 1 chorobie |
| SEMA3Asemaphorin 3A | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SETD1ASET domain containing 1A, histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| SKISKI proto-oncogene | Czasami (5–29%) | W 1 chorobie |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Czasami (5–29%) | W 1 chorobie |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Czasami (5–29%) | W 1 chorobie |
| SMOsmoothened, frizzled class receptor | Czasami (5–29%) | W 1 chorobie |
| SOX10SRY-box transcription factor 10 | Czasami (5–29%) | W 1 chorobie |
| SOX2SRY-box transcription factor 2 | Czasami (5–29%) | W 1 chorobie |
| SOX3SRY-box transcription factor 3 | Czasami (5–29%) | W 1 chorobie |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 2 chorobach |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Czasami (5–29%) | W 2 chorobach |
| SPRY4sprouty RTK signaling antagonist 4 | Czasami (5–29%) | W 1 chorobie |
| SRYsex determining region Y | Czasami (5–29%) | W 1 chorobie |
| STEEP1STING1 ER exit protein 1 | Czasami (5–29%) | W 1 chorobie |
| STX16syntaxin 16 | Czasami (5–29%) | W 1 chorobie |
| SUFUSUFU negative regulator of hedgehog signaling | Czasami (5–29%) | W 1 chorobie |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Czasami (5–29%) | W 1 chorobie |
| SYNE2spectrin repeat containing nuclear envelope protein 2 | Czasami (5–29%) | W 1 chorobie |
| TACR3tachykinin receptor 3 | Czasami (5–29%) | W 1 chorobie |
| TAF1TATA-box binding protein associated factor 1 | Czasami (5–29%) | W 1 chorobie |
| TERTtelomerase reverse transcriptase | Czasami (5–29%) | W 1 chorobie |
| TMEM43transmembrane protein 43 | Czasami (5–29%) | W 1 chorobie |
| TNFSF4TNF superfamily member 4 | Czasami (5–29%) | W 1 chorobie |
| TOGARAM1TOG array regulator of axonemal microtubules 1 | Czasami (5–29%) | W 1 chorobie |
| TRAF7TNF receptor associated factor 7 | Czasami (5–29%) | W 1 chorobie |
| UBE4Bubiquitination factor E4B | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| WACWW domain containing adaptor with coiled-coil | Czasami (5–29%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Czasami (5–29%) | W 1 chorobie |
| WT1WT1 transcription factor | Czasami (5–29%) | W 2 chorobach |
| ZNF365zinc finger protein 365 | Czasami (5–29%) | W 1 chorobie |
| ABCC8ATP binding cassette subfamily C member 8 | Rzadko (1–4%) | W 1 chorobie |
| ACADVLacyl-CoA dehydrogenase very long chain | Rzadko (1–4%) | W 1 chorobie |
| APPL1adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | Rzadko (1–4%) | W 1 chorobie |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Rzadko (1–4%) | W 2 chorobach |
| CELcarboxyl ester lipase | Rzadko (1–4%) | W 1 chorobie |
| DMPKDM1 protein kinase | Rzadko (1–4%) | W 1 chorobie |
| EXOC6Bexocyst complex component 6B | Rzadko (1–4%) | W 1 chorobie |
| GCKglucokinase | Rzadko (1–4%) | W 1 chorobie |
| HNF1AHNF1 homeobox A | Rzadko (1–4%) | W 1 chorobie |
| HNF4Ahepatocyte nuclear factor 4 alpha | Rzadko (1–4%) | W 1 chorobie |
| INSinsulin | Rzadko (1–4%) | W 1 chorobie |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Rzadko (1–4%) | W 1 chorobie |
| KLF11KLF transcription factor 11 | Rzadko (1–4%) | W 1 chorobie |
| NEUROD1neuronal differentiation 1 | Rzadko (1–4%) | W 1 chorobie |
| PAX4paired box 4 | Rzadko (1–4%) | W 1 chorobie |
| PDX1pancreatic and duodenal homeobox 1 | Rzadko (1–4%) | W 1 chorobie |
| SLC10A7solute carrier family 10 member 7 | Rzadko (1–4%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Rzadko (1–4%) | W 1 chorobie |
| TCF20transcription factor 20 | Rzadko (1–4%) | W 1 chorobie |
| TMEM216transmembrane protein 216 | Rzadko (1–4%) | W 1 chorobie |
| ABHD5abhydrolase domain containing 5, lysophosphatidic acid acyltransferase | Nie odnotowano | W 1 chorobie |
| ADRB3adrenoceptor beta 3 | Nie odnotowano | W 1 chorobie |
| AGRPagouti related neuropeptide | Nie odnotowano | W 1 chorobie |
| AIPAHR interacting HSP90 co-chaperone | Nie odnotowano | W 1 chorobie |
| CARTPTCART prepropeptide | Nie odnotowano | W 1 chorobie |
| CELA2Achymotrypsin like elastase 2A | Nie odnotowano | W 1 chorobie |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Nie odnotowano | W 1 chorobie |
| FTOFTO alpha-ketoglutarate dependent dioxygenase | Nie odnotowano | W 1 chorobie |
| GHRLghrelin and obestatin prepropeptide | Nie odnotowano | W 1 chorobie |
| H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | Nie odnotowano | W 1 chorobie |
| MC3Rmelanocortin 3 receptor | Nie odnotowano | W 1 chorobie |
| MRAP2melanocortin 2 receptor accessory protein 2 | Nie odnotowano | W 1 chorobie |
| NR0B2nuclear receptor subfamily 0 group B member 2 | Nie odnotowano | W 1 chorobie |
| PHF6PHD finger protein 6 | Nie odnotowano | W 1 chorobie |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Nie odnotowano | W 1 chorobie |
| PPARGperoxisome proliferator activated receptor gamma | Nie odnotowano | W 1 chorobie |
| PTENphosphatase and tensin homolog | Nie odnotowano | W 1 chorobie |
| SDC3syndecan 3 | Nie odnotowano | W 1 chorobie |
| SETD2SET domain containing 2, histone lysine methyltransferase | Nie odnotowano | W 1 chorobie |
| UCP3uncoupling protein 3 | Nie odnotowano | W 1 chorobie |
| USP8ubiquitin specific peptidase 8 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni